We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

238 hedge funds and large institutions have $1.61B invested in Editas Medicine in 2020 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 77 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

258% more call options, than puts

Call options by funds: $47.4M | Put options by funds: $13.2M

235% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 17

76% more capital invested

Capital invested by funds: $912M → $1.61B (+$696M)

54% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 50

20% more funds holding

Funds holding: 199 → 238 (+39)

5.12% more ownership

Funds ownership: 83.69% → 88.82% (+5.1%)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
238
Holders Change
+39
Holders Change %
+19.6%
% of All Funds
4.88%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
57
Increased
77
Reduced
50
Closed
17
Calls
$47.4M
Puts
$13.2M
Net Calls
+$34.1M
Net Calls Change
+$24.7M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$57.8M
2
CCM
CAAS Capital Management
New York
+$36.5M
3
State Street
State Street
Massachusetts
+$27.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$27.4M
5
BlackRock
BlackRock
New York
+$20.8M

Top Sellers

1
GTP
Global Thematic Partners
New York
-$8M
2
Victory Capital Management
Victory Capital Management
Texas
-$7.83M
3
NAMA
Nikko Asset Management Americas
New York
-$3M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.87M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$223M +$57.8M +2,210,205 +41%
Vanguard Group
2
Vanguard Group
Pennsylvania
$170M +$27.4M +1,048,440 +22%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$148M -$2.87M -109,848 -2%
BlackRock
4
BlackRock
New York
$148M +$20.8M +795,631 +19%
NAMA
5
Nikko Asset Management Americas
New York
$146M -$3M -114,622 -2%
State Street
6
State Street
Massachusetts
$91.2M +$27.5M +1,053,970 +52%
Capital World Investors
7
Capital World Investors
California
$52.1M – – –
Federated Hermes
8
Federated Hermes
Pennsylvania
$50.4M +$6.99M +267,500 +19%
CCM
9
CAAS Capital Management
New York
$41.3M +$36.5M +1,396,053 New
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$37.8M +$6.1M +233,592 +22%
DM
11
Deerfield Management
New York
$34.3M – – –
Chevy Chase Trust
12
Chevy Chase Trust
Maryland
$33.2M +$2.44M +93,368 +9%
CS
13
Credit Suisse
Switzerland
$30.1M +$724K +27,689 +3%
Morgan Stanley
14
Morgan Stanley
New York
$29.3M +$5.93M +227,068 +30%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$26.3M +$2.75M +105,111 +13%
Goldman Sachs
16
Goldman Sachs
New York
$22.9M +$2.97M +113,677 +17%
Northern Trust
17
Northern Trust
Illinois
$22.6M +$3.47M +132,894 +21%
Norges Bank
18
Norges Bank
Norway
$19.4M -$384K -14,678 -2%
Two Sigma Advisers
19
Two Sigma Advisers
New York
$17.9M -$23.5K -900 -0.1%
APM
20
Avidity Partners Management
Texas
$17.7M +$15.7M +600,000 New
Two Sigma Investments
21
Two Sigma Investments
New York
$13.9M +$2.38M +91,207 +24%
Viking Global Investors
22
Viking Global Investors
Connecticut
$12.2M -$2.59M -99,179 -19%
Charles Schwab
23
Charles Schwab
California
$11.6M +$1.5M +57,361 +17%
JP Morgan Chase
24
JP Morgan Chase
New York
$10.7M +$2.67M +102,290 +39%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$9.36M +$1.58M +60,383 +24%
1
2 3 4 5

EDIT Hedge Fund Activity: Q2 2020 in Review

238 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2020, worth a combined $1.61B — up 76% from $912M a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new EDIT positions and 17 closed out — a net gain of 40 holders — while 77 added to existing stakes and 50 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $57.8M. The largest seller was Global Thematic Partners, exiting entirely with an estimated $8M sold.

  • 238 institutional investors held Editas Medicine (EDIT) as of Q2 2020, up from 199 in Q1 2020.
  • Funds reported $1.61B of Editas Medicine stock for Q2 2020, up 76% quarter-over-quarter.
  • 57 funds opened new Editas Medicine positions in Q2 2020 and 17 closed out, a net change of +40 holders.
  • The largest Editas Medicine buyer in Q2 2020 was ARK Investment Management, an estimated $57.8M added.
  • The largest Editas Medicine seller in Q2 2020 was Global Thematic Partners, an estimated $8M sold.

Based on aggregated 13F filings for Q2 2020.